BIOGEN MA INC.

QALSODY

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

BIOGEN MA INC.

Qalsody HCPCS:

J1304

HCPCS Code Descriptor:

Injection, tofersen, 1 mg

Category:

J Code

Qalsody NDCs:

64406-0109-01

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intrathecal

Qalsody CPT Codes:

Potential CPT administration codes for Qalsody can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Qalsody:

QALSODY is a Neurology drug manufactured by BIOGEN MA INC. and administered via the Intrathecal route of administration. The J Code: J1304 is aligned to the drug QALSODY.

Qalsody is an injection used to treat ALS in adults caused by a genetic mutation in the SOD1 gene. Qalsody works by reducing the amount of a certain toxic protein in the body. The toxic protein is called the SOD1 protein, and it can cause damage to the motor neurons and worsen the symptoms of ALS. Qalsody can slow the progression of the disease, and can slow symptoms such as muscle weakness and loss of functions.

ACCESS PRICING AND MORE BY REGISTERING

J1304 Added Date:

January 1, 2024

J1304 Effective Date:

January 1, 2024

J1304 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Qalsody billing and coding information.
Qalsody patient assistance information can be found through Biogen at the URL: https://www.qalsodyhcp.com/
QALSODY prescribing information can be found at the link below:
Information regarding QALSODY’s side effects can be found at MedlinePlus